LeonaBio, Inc. (LONA)
6.34
-0.45
(-6.63%)
USD |
NASDAQ |
Sep 21, 16:00
6.34
0.00 (0.00%)
After-Hours: 20:00
LeonaBio Debt to Equity Ratio : 0.0172 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0172 |
| March 31, 2026 | 0.014 |
| December 31, 2025 | 0.0289 |
| September 30, 2025 | 0.034 |
| June 30, 2025 | 0.0318 |
| March 31, 2025 | 0.0299 |
| December 31, 2024 | 0.0271 |
| September 30, 2024 | 0.0228 |
| June 30, 2024 | 0.0169 |
| March 31, 2024 | 0.014 |
| December 31, 2023 | 0.0122 |
| September 30, 2023 | 0.0108 |
| June 30, 2023 | 0.0095 |
| March 31, 2023 | 0.0087 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.0081 |
| September 30, 2022 | 0.0076 |
| June 30, 2022 | 0.0073 |
| March 31, 2022 | 0.0061 |
| December 31, 2021 | 0.006 |
| September 30, 2021 | 0.0059 |
| June 30, 2021 | 0.0058 |
| March 31, 2021 | 0.0052 |
| December 31, 2020 | 0.0036 |
| September 30, 2020 | 0.0037 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | |
| December 31, 2019 | -0.5812 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cocrystal Pharma, Inc. | 1.284 |
| CNBX Pharmaceuticals, Inc. | -0.4388 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 0.0146 |
| Fulcrum Therapeutics, Inc. | 0.017 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 56.89M |
| Total Liabilities (Quarterly) | 23.30M |
| Shareholders Equity (Quarterly) | 33.60M |
| Current Ratio | 7.011 |
| Net Debt Paydown Yield | 0.12% |